Prue Cormie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Prue Cormie has a total of 213 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Abido Galvao
Exercise Medicine Research Institute Edith Cowan University Joondalup Western Australia Australia
28 shared publications Robert U. Newton
Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia
23 shared publications- Dennis R. Taaffe
Exercise Medicine Research Institute Edith Cowan University Joondalup Western Australia Australia
15 shared publications - Suzanne Kathleen Chambers
Faculty of Health Sciences, Australian Catholic University, Brisbane, Australia
15 shared publications Nigel Spry
Exercise Medicine Research Institute, Edith Cowan University, Joondalup, Western Australia, Australia
12 shared publications- Robert U. Newton
Exercise Medicine Research Institute, Edith Cowan University, Perth, Australia
11 shared publications
Latest Publications
- Open Access
- 25 March 2025
- Published by Springer Nature in Journal of Cancer Survivorship
- Vol. 20 (S1) , 1-15
What patients with cancer require from their clinicians to enable uptake of exercise as part of cancer care: A mixed methods study
Purpose: Despite robust evidence and a series of evidence-based guidelines stating the benefits of exercise for cancer patients, uptake remains low. This study aimed to explore and describe what patients with cancer require from their clinicians to enable uptake of exercise as part of cancer care. Methods: Concurrent mixed methods design. Participants included adult cancer patients. Online questionnaires and semi-structured telephone interviews explored patient preferences for receiving information about the role of exercise in cancer care. Quantitative data were analysed using standard descriptive statistics and an interpretive descriptive approach was used to inform qualitative analysis. Results: Participants included 456 cancer patients. A randomly selected sub-set of 30 patients completed an interview. Many participants (n = 280/61.6%) reported discussion with clinicians as the way they mostly preferred to receive exercise information. Receiving exercise information shortly after being diagnosed and before starting treatment (n = 186/41.1% and n = 90/19.9%) were the timepoints mostly preferred for being informed about exercise. Information that was personalised and described exercise as being important to their cancer care was reported to be more likely to influence exercise behaviour. Clinician actions/provision of resources ranked as most helpful were: referral to cancer-specific exercise specialist (n = 330/76.6%) or program (n = 310/71.8%), and written exercise recommendations from a doctor/nurse (n = 234/54.3%). Conclusions and Implications for Cancer Survivors: Cancer patients would be more likely to consider exercise as part of their cancer care if their clinicians initiated an informed conversation about exercise, introduced early in the care continuum, using personalised and cancer-specific messaging, that was supported by referral to cancer-specific exercise services.
- 25 March 2025
- Published by Springer Nature in Journal of Cancer Survivorship
- Vol. 20 (S1) , 1-15
Open AccessWhat patients with cancer require from their clinicians to enable uptake of exercise as part of cancer care: A mixed methods study
Purpose: Despite robust evidence and a series of evidence-based guidelines stating the benefits of exercise for cancer patients, uptake remains low. This study aimed to explore and describe what patients with cancer require from their clinicians to enable uptake of exercise as part of cancer care. Methods: Concurrent mixed methods design. Participants included adult cancer patients. Online questionnaires and semi-structured telephone interviews explored patient preferences for receiving information about the role of exercise in cancer care. Quantitative data were analysed using standard descriptive statistics and an interpretive descriptive approach was used to inform qualitative analysis. Results: Participants included 456 cancer patients. A randomly selected sub-set of 30 patients completed an interview. Many participants (n = 280/61.6%) reported discussion with clinicians as the way they mostly preferred to receive exercise information. Receiving exercise information shortly after being diagnosed and before starting treatment (n = 186/41.1% and n = 90/19.9%) were the timepoints mostly preferred for being informed about exercise. Information that was personalised and described exercise as being important to their cancer care was reported to be more likely to influence exercise behaviour. Clinician actions/provision of resources ranked as most helpful were: referral to cancer-specific exercise specialist (n = 330/76.6%) or program (n = 310/71.8%), and written exercise recommendations from a doctor/nurse (n = 234/54.3%). Conclusions and Implications for Cancer Survivors: Cancer patients would be more likely to consider exercise as part of their cancer care if their clinicians initiated an informed conversation about exercise, introduced early in the care continuum, using personalised and cancer-specific messaging, that was supported by referral to cancer-specific exercise services.
- 8 January 2025
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (2) , 1-13
Willingness to pay for exercise oncology services: a mixed methods study
Purpose To evaluate cancer patients’ willingness to pay for exercise services and oncology health professionals’ perception of patients’ willingness to pay. Methods A mixed-methods design was used. Online questionnaires and semi-structured interviews were administered to people with any type of cancer and oncology health professionals delivering clinical care. Questionnaires assessed patients’ willingness to pay for one consultation with a cancer-trained exercise specialist (i.e. exercise physiologist/physiotherapist) and regular group exercise sessions supervised by cancer-trained exercise specialists. Interviews probed factors associated with the out-of-pocket cost of adopting exercise guidelines. Data were analysed using standard descriptive statistics and an interpretive descriptive approach to qualitative analysis. Results Participants included 450 cancer patients and 300 oncology health professionals. A randomly selected sub-set of 30 patients and 31 health professionals completed interviews. The majority of patients surveyed would pay for an exercise consultation (94%) and regular group exercise sessions (58.4% extremely likely; 24.7% moderately likely; standard 7-point Likert scale response options). A greater proportion of patients who were employed (97.2% p = 0.030), below average general health (97.0% p = 0.031), were female (96.1% p = 0.013), and insufficiently active (95.3% p = 0.048) were willing to pay for exercise services. Oncology health professionals perceived fewer patients would be willing to pay for exercise services (p < 0.001; consultation = 7.0% extremely likely, 32.7% moderately likely; regular supervised sessions = 5.3% extremely likely; 32.0% moderately likely). Conclusions When briefly informed of the benefits and costs of exercise, the majority of patients in this study would pay for cancer-specific exercise services. There is an opportunity to align perceptions of willingness to pay among patients and health professionals involved in their care to help facilitate the uptake of exercise guidelines.
- 8 January 2025
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (2) , 1-13
Willingness to pay for exercise oncology services: a mixed methods study
Purpose To evaluate cancer patients’ willingness to pay for exercise services and oncology health professionals’ perception of patients’ willingness to pay. Methods A mixed-methods design was used. Online questionnaires and semi-structured interviews were administered to people with any type of cancer and oncology health professionals delivering clinical care. Questionnaires assessed patients’ willingness to pay for one consultation with a cancer-trained exercise specialist (i.e. exercise physiologist/physiotherapist) and regular group exercise sessions supervised by cancer-trained exercise specialists. Interviews probed factors associated with the out-of-pocket cost of adopting exercise guidelines. Data were analysed using standard descriptive statistics and an interpretive descriptive approach to qualitative analysis. Results Participants included 450 cancer patients and 300 oncology health professionals. A randomly selected sub-set of 30 patients and 31 health professionals completed interviews. The majority of patients surveyed would pay for an exercise consultation (94%) and regular group exercise sessions (58.4% extremely likely; 24.7% moderately likely; standard 7-point Likert scale response options). A greater proportion of patients who were employed (97.2% p = 0.030), below average general health (97.0% p = 0.031), were female (96.1% p = 0.013), and insufficiently active (95.3% p = 0.048) were willing to pay for exercise services. Oncology health professionals perceived fewer patients would be willing to pay for exercise services (p < 0.001; consultation = 7.0% extremely likely, 32.7% moderately likely; regular supervised sessions = 5.3% extremely likely; 32.0% moderately likely). Conclusions When briefly informed of the benefits and costs of exercise, the majority of patients in this study would pay for cancer-specific exercise services. There is an opportunity to align perceptions of willingness to pay among patients and health professionals involved in their care to help facilitate the uptake of exercise guidelines.
- Open Access
- 3 February 2023
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
- Vol. 10 (3) , 261-270
A feasibility, safety, and efficacy evaluation of supervised aerobic and resistance exercise for patients with glioblastoma undertaking adjuvant chemoradiotherapy
Background: While therapeutically effective, chemoradiotherapy treatment for high-grade glioma (glioblastoma) is often accompanied by side effects. Exercise has been demonstrated to alleviate the adverse effects of such treatments in other cancers. We aimed to evaluate the feasibility and preliminary efficacy of supervised exercise incorporating autoregulation. Methods: Thirty glioblastoma patients were recruited, five declined exercise and 25 were provided with a multimodal exercise intervention for the duration of their chemoradiotherapy treatment. Patient recruitment, retention, adherence to training sessions and safety were evaluated throughout the study. Physical function, body composition, fatigue, sleep quality, and quality of life were evaluated before and after the exercise intervention. Results: Eight of the 25 participants commencing exercise withdrew prior to completion of the study (32%). Seventeen patients (68%) demonstrated low to high adherence (33%–100%) and exercise dosage compliance (24%–83%). There were no reported adverse events. Significant improvements were observed for all trained exercises and lower limb muscle strength and function with no significant changes observed for any other physical function, body composition, fatigue, sleep, or quality of life outcomes. Conclusions: Only half of glioblastoma patients recruited were willing or able to commence, complete or meet minimum dose compliance for the exercise intervention during chemoradiotherapy indicating the intervention evaluated may not be feasible for part of this patient cohort. For those who were able to complete the exercise program, supervised, autoregulated, multimodal exercise was safe and significantly improved strength and function and may have prevented deterioration in body composition and quality of life.
- 3 February 2023
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
- Vol. 10 (3) , 261-270
Open AccessA feasibility, safety, and efficacy evaluation of supervised aerobic and resistance exercise for patients with glioblastoma undertaking adjuvant chemoradiotherapy
Background: While therapeutically effective, chemoradiotherapy treatment for high-grade glioma (glioblastoma) is often accompanied by side effects. Exercise has been demonstrated to alleviate the adverse effects of such treatments in other cancers. We aimed to evaluate the feasibility and preliminary efficacy of supervised exercise incorporating autoregulation. Methods: Thirty glioblastoma patients were recruited, five declined exercise and 25 were provided with a multimodal exercise intervention for the duration of their chemoradiotherapy treatment. Patient recruitment, retention, adherence to training sessions and safety were evaluated throughout the study. Physical function, body composition, fatigue, sleep quality, and quality of life were evaluated before and after the exercise intervention. Results: Eight of the 25 participants commencing exercise withdrew prior to completion of the study (32%). Seventeen patients (68%) demonstrated low to high adherence (33%–100%) and exercise dosage compliance (24%–83%). There were no reported adverse events. Significant improvements were observed for all trained exercises and lower limb muscle strength and function with no significant changes observed for any other physical function, body composition, fatigue, sleep, or quality of life outcomes. Conclusions: Only half of glioblastoma patients recruited were willing or able to commence, complete or meet minimum dose compliance for the exercise intervention during chemoradiotherapy indicating the intervention evaluated may not be feasible for part of this patient cohort. For those who were able to complete the exercise program, supervised, autoregulated, multimodal exercise was safe and significantly improved strength and function and may have prevented deterioration in body composition and quality of life.
- Top Cited PapersOpen Access
- 1 May 2022
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 18 (5) , e697-e709
Exercise Recommendation for People With Bone Metastases: Expert Consensus for Health Care Providers and Exercise Professionals
PURPOSE: Exercise has been underutilized in people with advanced or incurable cancer despite the potential to improve physical function and reduce psychosocial morbidity, especially for people with bone metastases because of concerns over skeletal complications. The International Bone Metastases Exercise Working Group (IBMEWG) was formed to develop best practice recommendations for exercise programming for people with bone metastases on the basis of published research, clinical experience, and expert opinion. METHODS: The IBMEWG undertook sequential steps to inform the recommendations: (1) modified Delphi survey, (2) systematic review, (3) cross-sectional survey to physicians and nurse practitioners, (4) in-person meeting of IBMEWG to review evidence from steps 1-3 to develop draft recommendations, and (5) stakeholder engagement. RESULTS: Recommendations emerged from the contributing evidence and IBMEWG discussion for pre-exercise screening, exercise testing, exercise prescription, and monitoring of exercise response. Identification of individuals who are potentially at higher risk of exercise-related skeletal complication is a complex interplay of these factors: (1) lesion-related, (2) cancer and cancer treatment–related, and (3) the person-related. Exercise assessment and prescription requires consideration of the location and presentation of bone lesion(s) and should be delivered by qualified exercise professionals with oncology education and exercise prescription experience. Emphasis on postural alignment, controlled movement, and proper technique is essential. CONCLUSION: Ultimately, the perceived risk of skeletal complications should be weighed against potential health benefits on the basis of consultation between the person, health care team, and exercise professionals. These recommendations provide an initial framework to improve the integration of exercise programming into clinical care for people with bone metastases.
- 1 May 2022
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 18 (5) , e697-e709
Top Cited PapersOpen AccessExercise Recommendation for People With Bone Metastases: Expert Consensus for Health Care Providers and Exercise Professionals
PURPOSE: Exercise has been underutilized in people with advanced or incurable cancer despite the potential to improve physical function and reduce psychosocial morbidity, especially for people with bone metastases because of concerns over skeletal complications. The International Bone Metastases Exercise Working Group (IBMEWG) was formed to develop best practice recommendations for exercise programming for people with bone metastases on the basis of published research, clinical experience, and expert opinion. METHODS: The IBMEWG undertook sequential steps to inform the recommendations: (1) modified Delphi survey, (2) systematic review, (3) cross-sectional survey to physicians and nurse practitioners, (4) in-person meeting of IBMEWG to review evidence from steps 1-3 to develop draft recommendations, and (5) stakeholder engagement. RESULTS: Recommendations emerged from the contributing evidence and IBMEWG discussion for pre-exercise screening, exercise testing, exercise prescription, and monitoring of exercise response. Identification of individuals who are potentially at higher risk of exercise-related skeletal complication is a complex interplay of these factors: (1) lesion-related, (2) cancer and cancer treatment–related, and (3) the person-related. Exercise assessment and prescription requires consideration of the location and presentation of bone lesion(s) and should be delivered by qualified exercise professionals with oncology education and exercise prescription experience. Emphasis on postural alignment, controlled movement, and proper technique is essential. CONCLUSION: Ultimately, the perceived risk of skeletal complications should be weighed against potential health benefits on the basis of consultation between the person, health care team, and exercise professionals. These recommendations provide an initial framework to improve the integration of exercise programming into clinical care for people with bone metastases.
- 20 April 2021
- Published by Wiley in European Journal of Cancer Care
- Vol. 30 (5) , e13453
Patients and carers' perspectives of participating in a pilot tailored exercise program during chemoradiotherapy for high grade glioma: A qualitative study
Objective To describe glioblastoma patients’ and carers’ perspectives of participating in a tailored exercise intervention during chemoradiotherapy. Methods A pilot study was conducted to evaluate if exercise was a feasible and safe therapy in patients with glioblastoma undergoing chemoradiotherapy. Patients received a supervised exercise intervention involving an individualised prescription of moderate‐intensity aerobic and resistance exercise twice weekly, performed at the hospital when they attended for treatment. Semi‐structured interviews were conducted with participants and their carers. Recordings were analysed using thematic analysis. Results 19 patients and 15 carers participated. Benefits and challenges of participating in the exercise intervention were described. Benefits included an individually tailored exercise program, improvements in health, regaining a sense of control, interacting with people, keeping active and benefits for carers. Challenges included managing symptoms associated with diagnosis and treatment, juggling treatment and exercise, and difficulties engaging in the program. Conclusion Patients and carers expressed positive perceptions and experiences of participating in exercise during chemoradiotherapy; however, some challenges were experienced. These results support the quantitative pilot study which demonstrated that supervised exercise is feasible, safe and well tolerated by patients receiving chemoradiotherapy for glioblastoma. Randomised controlled trials now need to be conducted with this population.
- 20 April 2021
- Published by Wiley in European Journal of Cancer Care
- Vol. 30 (5) , e13453
Patients and carers' perspectives of participating in a pilot tailored exercise program during chemoradiotherapy for high grade glioma: A qualitative study
Objective To describe glioblastoma patients’ and carers’ perspectives of participating in a tailored exercise intervention during chemoradiotherapy. Methods A pilot study was conducted to evaluate if exercise was a feasible and safe therapy in patients with glioblastoma undergoing chemoradiotherapy. Patients received a supervised exercise intervention involving an individualised prescription of moderate‐intensity aerobic and resistance exercise twice weekly, performed at the hospital when they attended for treatment. Semi‐structured interviews were conducted with participants and their carers. Recordings were analysed using thematic analysis. Results 19 patients and 15 carers participated. Benefits and challenges of participating in the exercise intervention were described. Benefits included an individually tailored exercise program, improvements in health, regaining a sense of control, interacting with people, keeping active and benefits for carers. Challenges included managing symptoms associated with diagnosis and treatment, juggling treatment and exercise, and difficulties engaging in the program. Conclusion Patients and carers expressed positive perceptions and experiences of participating in exercise during chemoradiotherapy; however, some challenges were experienced. These results support the quantitative pilot study which demonstrated that supervised exercise is feasible, safe and well tolerated by patients receiving chemoradiotherapy for glioblastoma. Randomised controlled trials now need to be conducted with this population.
- 1 February 2020
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 38 (2) , 62-70
Exercise medicine for the management of androgen deprivation therapy-related side effects in prostate cancer
- 1 February 2020
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 38 (2) , 62-70
Exercise medicine for the management of androgen deprivation therapy-related side effects in prostate cancer
- Open Access
- 1 March 2019
- Published by Elsevier in Mental Health and Physical Activity
- Vol. 16, 140-151
Health benefits, safety and cost of physical activity interventions for mental health conditions: A meta-review to inform translation efforts
- 1 March 2019
- Published by Elsevier in Mental Health and Physical Activity
- Vol. 16, 140-151
Open AccessHealth benefits, safety and cost of physical activity interventions for mental health conditions: A meta-review to inform translation efforts
- Open Access
- 21 September 2018
- Published by Wiley in BJU International
- Vol. 123 (2) , 261-269
Immediate versus delayed exercise in men initiating androgen deprivation: effects on bone density and soft tissue composition
Objectives: To examine whether it is more efficacious to commence exercise medicine in men with prostate cancer at the onset of androgen‐deprivation therapy (ADT) rather than later on during treatment to preserve bone and soft‐tissue composition, as ADT results in adverse effects including: reduced bone mineral density ( BMD ), loss of muscle mass, and increased fat mass (FM). Patients and methods: In all, 104 patients with prostate cancer, aged 48–84 years initiating ADT, were randomised to immediate exercise ( IMEX , n = 54) or delayed exercise ( DEL , n = 50) conditions. The former consisted of 6 months of supervised resistance/aerobic/impact exercise and the latter comprised 6 months of usual care followed by 6 months of the identical exercise programme. Regional and whole body BMD , lean mass (LM), whole body FM and trunk FM, and appendicular skeletal muscle ( ASM ) were assessed by dual X‐ray absorptiometry, and muscle density by peripheral quantitative computed tomography at baseline, and at 6 and 12 months. Results: There was a significant time effect ( P < 0.001) for whole body, spine and hip BMD with a progressive loss in the IMEX and DEL groups , although lumbar spine BMD was largely preserved in the IMEX group at 6 months compared with the DEL group (−0.4% vs −1.6%). LM, ASM , and muscle density were preserved in the IMEX group at 6 months, declined in the DEL group at 6 months (−1.4% to −2.5%) and then recovered at 12 months after training. FM and trunk FM increased ( P < 0.001) over the 12‐month period in the IMEX (7.8% and 4.5%, respectively) and DEL groups (6.5% and 4.3%, respectively). Conclusions: Commencing exercise at the onset of ADT preserves lumbar spine BMD , muscle mass, and muscle density. To avoid treatment‐related adverse musculoskeletal effects, exercise medicine should be prescribed and commenced at the onset of ADT .
- 21 September 2018
- Published by Wiley in BJU International
- Vol. 123 (2) , 261-269
Open AccessImmediate versus delayed exercise in men initiating androgen deprivation: effects on bone density and soft tissue composition
Objectives: To examine whether it is more efficacious to commence exercise medicine in men with prostate cancer at the onset of androgen‐deprivation therapy (ADT) rather than later on during treatment to preserve bone and soft‐tissue composition, as ADT results in adverse effects including: reduced bone mineral density ( BMD ), loss of muscle mass, and increased fat mass (FM). Patients and methods: In all, 104 patients with prostate cancer, aged 48–84 years initiating ADT, were randomised to immediate exercise ( IMEX , n = 54) or delayed exercise ( DEL , n = 50) conditions. The former consisted of 6 months of supervised resistance/aerobic/impact exercise and the latter comprised 6 months of usual care followed by 6 months of the identical exercise programme. Regional and whole body BMD , lean mass (LM), whole body FM and trunk FM, and appendicular skeletal muscle ( ASM ) were assessed by dual X‐ray absorptiometry, and muscle density by peripheral quantitative computed tomography at baseline, and at 6 and 12 months. Results: There was a significant time effect ( P < 0.001) for whole body, spine and hip BMD with a progressive loss in the IMEX and DEL groups , although lumbar spine BMD was largely preserved in the IMEX group at 6 months compared with the DEL group (−0.4% vs −1.6%). LM, ASM , and muscle density were preserved in the IMEX group at 6 months, declined in the DEL group at 6 months (−1.4% to −2.5%) and then recovered at 12 months after training. FM and trunk FM increased ( P < 0.001) over the 12‐month period in the IMEX (7.8% and 4.5%, respectively) and DEL groups (6.5% and 4.3%, respectively). Conclusions: Commencing exercise at the onset of ADT preserves lumbar spine BMD , muscle mass, and muscle density. To avoid treatment‐related adverse musculoskeletal effects, exercise medicine should be prescribed and commenced at the onset of ADT .
- 1 September 2018
- Published by Elsevier in The Lancet Oncology
- Vol. 19 (9) , e432-E432
Exercise as part of routine cancer care
- 1 September 2018
- Published by Elsevier in The Lancet Oncology
- Vol. 19 (9) , e432-E432
Exercise as part of routine cancer care
- Open Access
- 29 June 2018
- Published by SAGE Publications in American Journal of Men's Health
- Vol. 12 (6) , 1864-1872
Depression and Prostate Cancer: Examining Comorbidity and Male-Specific Symptoms
Depression in men with prostate cancer is a significant and complex issue that can challenge clinicians’ diagnostic efforts. The objective of the current study was to evaluate prototypic and male-specific depression symptoms and suicidal ideation in men with a diagnosis of prostate cancer relative to those with and without comorbidity. The Patient Health Questionnaire-9 (PHQ-9) and Male Depression Risk Scale-22 (MDRS-22) were completed online along with demographic and background variables by 100 men with a diagnosis of prostate cancer (n = 54 prostatectomy, n = 33 receiving active treatment). Hierarchical logistic regression was used to examine recent (past 2 weeks) suicide ideation. Over one-third of the sample (38%) reported a comorbidity, and this group had significantly higher total depression scores on the PHQ-9 (Cohen’s d = 0.65), MDRS-22 emotion suppression (d = 0.35), and drug use subscales (d = 0.38) compared to respondents without comorbidity. A total of 14% reported recent suicidal ideation, of which 71.4% of cases were identified by the PHQ-9 “moderate” cut-off, and 85.7% of cases were identified by the MDRS-22 “elevated” cut-off. After control variables, MDRS-22 subscales accounted for 45.1% of variance in recent suicidal ideation. While limited by the exclusive use of self-report data, findings point to the potential benefits of evaluating male-specific symptoms as part of depression and suicide risk screening in men with prostate cancer and the need to be mindful of the heightened risk for depression among men with prostate cancer who have comorbidity.
- 29 June 2018
- Published by SAGE Publications in American Journal of Men's Health
- Vol. 12 (6) , 1864-1872
Open AccessDepression and Prostate Cancer: Examining Comorbidity and Male-Specific Symptoms
Depression in men with prostate cancer is a significant and complex issue that can challenge clinicians’ diagnostic efforts. The objective of the current study was to evaluate prototypic and male-specific depression symptoms and suicidal ideation in men with a diagnosis of prostate cancer relative to those with and without comorbidity. The Patient Health Questionnaire-9 (PHQ-9) and Male Depression Risk Scale-22 (MDRS-22) were completed online along with demographic and background variables by 100 men with a diagnosis of prostate cancer (n = 54 prostatectomy, n = 33 receiving active treatment). Hierarchical logistic regression was used to examine recent (past 2 weeks) suicide ideation. Over one-third of the sample (38%) reported a comorbidity, and this group had significantly higher total depression scores on the PHQ-9 (Cohen’s d = 0.65), MDRS-22 emotion suppression (d = 0.35), and drug use subscales (d = 0.38) compared to respondents without comorbidity. A total of 14% reported recent suicidal ideation, of which 71.4% of cases were identified by the PHQ-9 “moderate” cut-off, and 85.7% of cases were identified by the MDRS-22 “elevated” cut-off. After control variables, MDRS-22 subscales accounted for 45.1% of variance in recent suicidal ideation. While limited by the exclusive use of self-report data, findings point to the potential benefits of evaluating male-specific symptoms as part of depression and suicide risk screening in men with prostate cancer and the need to be mindful of the heightened risk for depression among men with prostate cancer who have comorbidity.